KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $217,000 | +17.3% | 30,000 | 0.0% | 0.03% | -5.6% |
| Q1 2017 | $185,000 | +5.1% | 30,000 | 0.0% | 0.04% | +125.0% |
| Q4 2016 | $176,000 | +10.7% | 30,000 | 0.0% | 0.02% | -40.7% |
| Q3 2016 | $159,000 | -20.1% | 30,000 | 0.0% | 0.03% | -38.6% |
| Q2 2016 | $199,000 | +42.1% | 30,000 | 0.0% | 0.04% | +33.3% |
| Q1 2016 | $140,000 | +68.7% | 30,000 | +81.8% | 0.03% | +73.7% |
| Q4 2015 | $83,000 | – | 16,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
| VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
| Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
| HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
| Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
| SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
| NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
| Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |